TSPO and neoplasm: They found that TSPO tracer uptake significantly correlated with tumor grade at recurrence and that a median maximum standardized uptake value < 1.68 predicted significantly longer median post-recurrence survival (41.6 vs. 12.6 months) and median time to treatment failure (14.9 vs. 6.2 months) [34].